First, MTX functions as an antimetabolite by inhibiting dihydrofolate reductase (DHFR), preventing the conversion of folate to tetrahydrofolic acid (THF) and causing intracellular folate deficiency [10]. This evidence concerns the gene DHFR and folate deficiency.